The table below shows TEVA PHARMACEUTICAL INDUSTRIES LTD's cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Operating cash flow
-$40.00M
$369.00M
$227.00M
-$105.00M
$693.00M
$103.00M
Capital expenditure
-
-
-
-
-
-
Investing cash flow
$229.00M
$135.00M
$236.00M
$201.00M
$268.00M
$178.00M
Dividends paid
-
-
-
-
-
-
TEVA operating cash flow (10-K history)
TEVA PHARMACEUTICAL INDUSTRIES LTD reported operating cash flow of $1.65B for fiscal year 2025. That is up 32.2% from $1.25B in fiscal 2024. Over the 10 fiscal years shown, operating cash flow declined from $5.22B (FY 2016) to $1.65B. Figures come from the company's audited annual reports as filed with the SEC.
